Realcan Pharmaceutical Group Co Ltd
SZSE:002589
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Realcan Pharmaceutical Group Co Ltd
SZSE:002589
|
CN |
|
X
|
Xybion Digital Inc
XTSX:XYBN
|
CA |
|
Shinsun Holdings Group Co Ltd
HKEX:2599
|
CN |
|
C
|
CCFNB Bancorp Inc
OTC:CCFN
|
US |
|
A
|
Atmofizer Technologies Inc
CNSX:ATMO
|
CA |
|
R
|
Rallybio Corp
NASDAQ:RLYB
|
US |
|
E
|
EDP Renovaveis SA
ELI:EDPR
|
ES |
|
GN Store Nord A/S
OTC:GGNDF
|
DK |
|
T
|
Toshiba Tec Corp
TSE:6588
|
JP |
|
R
|
Riyue Heavy Industry Co Ltd
SSE:603218
|
CN |
Dividends
Dividend Yield
Realcan Pharmaceutical Group Co Ltd
| Current Yield | |
| Min Yield | |
| Max Yield | |
| Average Yield | |
| Median Yield |
Dividend Per Share
Realcan Pharmaceutical Group Co Ltd
Realcan Pharmaceutical Group Co Ltd have
decreased
by 0%.
Payout Ratio
Realcan Pharmaceutical Group Co Ltd
Peers Comparison
Dividends
Shareholder Yield
Current shareholder yield for Realcan Pharmaceutical Group Co Ltd is
hidden
.
Peers Comparison
Shareholder Yield
Buybacks
Buyback Yield measures how much a company reduces its outstanding shares through repurchases, expressed as a percentage.
This metric directly reflects the company’s efforts to return value to shareholders. By reducing the number of shares, buybacks can increase earnings per share and potentially boost the stock's price.
Peers Comparison
Buybacks
Debt Paydown
Debt Paydown Yield measures the amount of debt a company repays within a specific period, shown as a percentage of its market capitalization.
This metric indicates how the company is using its capital to decrease financial liabilities, which can strengthen its financial health and potentially enhance shareholder value.
Peers Comparison
Debt Paydown
Price Appreciation
Price
Realcan Pharmaceutical Group Co Ltd
| Average Annual Return | -10.54% |
| Standard Deviation of Annual Returns | 11.92% |
| Max Drawdown | -66% |
| Market Capitalization | 5.4B CNY |
| Shares Outstanding | 1 504 710 000 |
| Percentage of Shares Shorted |
N/A
|
Return Decomposition
Main factors of price return
Stock Splits
Realcan Pharmaceutical Group Co Ltd's latest stock split occurred on May 15, 2017
The company executed a 23-for-10 stock split, meaning that for every 10 shares held, investors received 23 new shares.
Before the split, Realcan Pharmaceutical Group Co Ltd traded at 37.88 per share. Afterward, the share price was about 16.1534.
The adjusted shares began trading on May 15, 2017. This was Realcan Pharmaceutical Group Co Ltd's 3rd stock split, following the previous one in Sep 23, 2015.
